Patent strategy in the crop-protection sector is frequently centred on the active ingredient. Considerable commercial value may, however, continue to be created after the active molecule itself has been identified.

The formulation determines how an active ingredient performs as a commercial agricultural product. Surfactants, solvents, safeners, stabilisers, carriers, concentration ranges, crystal forms and component ratios may affect storage stability, efficacy, crop safety, uptake, handling and field performance. Developing an effective formulation can therefore involve substantial technical work in its own right.

South African patent law is sufficiently broad to protect qualifying inventions of this nature. A formulation that satisfies the statutory requirements of novelty, inventive step and industrial or agricultural applicability may be capable of patent protection, even where its individual components are already known.

Stauffer Chemical Company v Safsan Marketing and Distribution provides an established South African example from the crop-protection sector. The patent concerned herbicidal compositions combining an active herbicidal compound with an antidote or safener intended to reduce injury to the crop. The proceedings required detailed consideration of the composition itself and the scope of the relevant patent claims.

Formulation protection can assume increasing importance during the later stages of a product lifecycle.

An originator may continue developing improved formulations or dosage regimes after protection over the underlying active ingredient has been secured. Those subsequent developments can extend the broader IP portfolio where they satisfy the requirements for patentability. Conversely, a manufacturer preparing to enter the market after expiry of an active-ingredient patent cannot assume that every commercially viable formulation is available for unrestricted use.

Technical development should therefore be reviewed for patent potential throughout the life of the product rather than only at the point at which the active ingredient is first discovered.

An unexpected improvement in stability, a reduction in crop damage, an enhanced delivery profile or another demonstrable technical effect may justify further patent analysis. Experimental evidence will usually be central to that assessment, particularly where the development involves components that are individually well known.

The regulatory process can also expose technical developments of potential IP significance. The Department of Agriculture’s chemistry requirements include information relating to formulated products and storage stability. Work undertaken to satisfy regulatory requirements may therefore generate technical results that warrant separate consideration from a patent perspective.

Coordination between regulatory and patent teams becomes particularly important at this stage. Potentially patentable developments should be identified before any disclosure that could prejudice protection. Information that does not require patent publication may instead form part of the business’s confidential technical know-how.

A mature crop-protection IP portfolio may consequently contain several layers of protection. Rights over the active ingredient may sit alongside patents directed to formulations, combinations, crystal forms, dosage regimes, processes or other improvements, supported by confidential information and regulatory data.

Assessing those layers individually can leave gaps in protection. Considered together, they provide a more complete view of the intellectual property supporting the commercial product.

KISCH IP assists crop-protection businesses in identifying and protecting formulation and dosage regime innovation as part of a broader product and portfolio strategy.